StockGlow

Mabpharm Limited (2181.HK)

Mabpharm Limited, a biopharmaceutical company, engages in research, development, production, and commercialization of drugs and biosimilar for cancers and autoimmune diseases in the People's Republic of China.

0.40+0.00%Healthcare
Compare 2181.HK with
StockGlow Score
9
Bearish
BearishBullish
1 year ago-25.9%

The outlook

Mabpharm Limited currently reads as bearish based on below its 50- & 200-day averages, 16% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range16% of the way from its 52-week low to high
Market cap
$1.65B
52-wk high
0.88
52-wk low
0.31
50-day avg
0.41
200-day avg
0.49
Trailing P/E
40.0

Similar stocks

1875.HKBioDlink International Company Limited$3.25-0.61%3681.HKSinoMab BioScience Limited$1.27+4.10%2616.HKCStone Pharmaceuticals$4.35-1.36%2552.HKHua Medicine (Shanghai) Ltd.$2.35-3.29%2189.HKKato (Hong Kong) Holdings Limited$0.49+1.03%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy